# Evoxx Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evoxx-technologies

- Industry: Biotechnology
- Headquarters: Germany
- Website: www.evoxx.com
- Total disclosed funding: $7.2M
- Latest round: Series B (Jun 24, 2013)
- Investors on record: 5

## About

Founded in 2006 and based in Germany, Evoxx Technologies GmbH operated as an industrial biotechnology company that focuses on the development and production of industrial enzymes and novel carbohydrate ingredients produced by enzymatic bioconversion.

## Funding rounds

- Series B, Jun 24, 2013, $4.7M — Sirius Equity Partners, NRW Bank, High-Tech Gruenderfonds, Lanxess Group, Riesner Verwaltungs GmbH
- Series A, Jul 6, 2010, $2.5M — Sirius Equity Partners, High-Tech Gruenderfonds, Riesner Verwaltungs GmbH
- Seed, Sep 1, 2007 — Sirius Equity Partners, High-Tech Gruenderfonds

## Investors

- Sirius Equity Partners (https://capitalatlas.ai/funds/sirius-equity-partners) — Seed, Series A, Series B
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed, Series A, Series B
- Riesner Verwaltungs GmbH — Series A, Series B
- NRW Bank — Series B
- Lanxess Group — Series B